MethylprednisoloneIgE mediated hypersensitivity: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2035卷 / 1期

关键词：

D O I：

10.1007/s40278-024-71028-0

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：278 / 278

相关论文

共 50 条

[31] BCGKidney disorders due to immune mediated hypersensitivity reaction to BCG: case report
Reactions Weekly, 2018, 1714 (1) : 68 - 68
[32] Alirocumab/evolocumabIgE-mediated hypersensitivity and cross-reactivity : case report
Reactions Weekly, 2021, 1876 (1) : 25 - 25
[33] OcrelizumabIgE-mediated hypersensitivity reaction with subsequent successful desensitisation: case report
Reactions Weekly, 2020, 1807 (1) : 149 - 149
[34] Methylprednisolone sodium succinateIgE-mediated immediate hypersensitivity reaction: case report
Reactions Weekly, 2019, 1772 (1) : 223 - 223
[35] Icatibant/methylprednisoloneImmunoglobulin E-mediated hypersensitivity and lack of efficacy: case report
Reactions Weekly, 2021, 1836 (1) : 385 - 385
[36] Tranexamic acidIgE-mediated type I hypersensitivity reaction: case report
Reactions Weekly, 2015, 1578 (1) : 283 - 283
[37] Amoxicillin/clavulanic-acidImmunoglobulin-E mediated isolated hypersensitivity: case report
Reactions Weekly, 2020, 1829 (1) : 46 - 46
[38] VancomycinDrug hypersensitivity: case report
Reactions Weekly, 2010, 1285 (1) : 27 - 27
[39] CyclophosphamideDrug hypersensitivity: case report
Reactions Weekly, 2005, 1064 (1) : 9 - 9
[40] VancomycinDelayed hypersensitivity: case report
Reactions Weekly, 2001, 872 (1) : 11 - 11

← 1 2 3 4 5 →